在患有阿迪森危机的狗中,暂时的三度心房塞
Paula Maria Pașca1, Gheorghe Solcan1, Andrei Blageanu1
1Department of Clinics, Faculty of Veterinary Medicine, "Ion Ionescu de la Brad" Iasi University of Life Sciences, 700490 Iasi, Romania.
Veterinary sciences
|January 24, 2025
概括
狗的低 adrenocorticism 可能会导致严重的心脏问题,如三度心房静脉阻塞. 使用特定药物的及时治疗可以扭转这些心脏并发症,避免需要起器.
科学领域:
- 兽医心脏病学 兽医心脏病学
- 狗内分泌学 狗内分泌学
背景情况:
- 皮肤上腺下降症 (亚迪森病) 是一种复杂的内分泌系统疾病,影响着狗.
- 心脏异常,包括心房静脉阻塞,是潜在的,但不太常见的后果.
研究的目的:
- 在狗中报告第三级心房静脉阻塞的病例,该病例是二次的 hypoadrenocorticism.
- 为了突出心脏导电异常的潜在可逆性,适当的治疗.
- 强调在出现心脏和电解质障碍的狗中考虑低 adrenocorticism 的重要性.
主要方法:
- 一个3岁的拉布拉多犬的临床病例介绍,具有典型的低皮质皮质症迹象.
- 诊断工作包括血清生物化学,基本皮质醇水平,腹部超声波和心电图 (ECG).
- 用液体复苏,皮质类固醇和矿物质皮质类固醇进行治疗干预,其次是口服普雷迪尼索隆和脱氧皮质皮瓦酸盐.
主要成果:
- 患者呈现出严重的高血,低血,低血糖,心和低血压.
- 电脑心电图显示出一个完整的心房静脉阻塞.
- 治疗导致了临床症状的快速改善,电解质正常化,以及心房静脉阻塞的解决.
结论:
- 第三度心房静脉阻塞可能是犬类低皮质性皮质症的可逆表现.
- 对低 adrenocorticism 的特定治疗可以解决严重的心脏导电障碍.
- 对于与狗的低 adrenocorticism 相关的心房门阻塞,心脏起器植入并不总是必要的.
相关概念视频
01:28Disturbances in Heart Rhythm
889
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
889
01:12Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
895
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
895
01:23Acute Respiratory Failure-IV
125
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
125
01:30Acute Respiratory Failure-III
153
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
153
01:24Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
706
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
706
01:21Acute Respiratory Failure-II
168
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
168